Early detection and intervention of neuromuscular diseases is critical in order to deliver comprehensive and high-quality healthcare to obtain the highest possible quality of life. MDA advocates for access to healthcare and other vital services from the moment a baby...

We are committed to working with key stakeholders, including the US Food and Drug Administration (FDA), to help accelerate the development of life-changing therapies. Below are our priorities to accelerate therapeutic development.MDA's Accelerating Therapy Development...

MDA works daily to ensure that members of the neuromuscular community can learn, work, travel, and socialize without discrimination. We will continue to advance policy changes that maximize our community’s access to key programs and services.MDA's empowerment and...

MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS, and related neuromuscular diseases. Please see the resources below for a sampling of statements and communications to policymakers on a number of issues that affect the neuromuscular...